Salmaan Keshavjee




Dr. Keshavjee is an associate professor in the Department of Global Health and Social Medicine and Department of Medicine at Harvard Medical School. He also serves as a physician in the Division of Global Health Equity at the Brigham and Women’s Hospital. He conducted doctoral research in medical anthropology at Harvard University on the health transition in post-Soviet Tajikistan. He has worked with the Division of Global Health Equity and Partners In Health on the implementation of a multidrug-resistant tuberculosis (MDR-TB) treatment program in Tomsk, Russia. Between 2000 and 2008, Dr. Keshavjee set up a program to treat patients co-infected with HIV and MDR-TB in Lesotho. Between 2007 and 2010, Dr. Keshavjee served as the chair of the Green Light Committee Initiative, a Stop TB Partnership/WHO initiative which helps countries gain access to high-quality second-line anti-TB drugs so they can provide treatment for people with MDR-TB in line with the WHO guidelines, the latest scientific evidence, and country experiences. He is currently a member of the Stop TB Partnership’s MDR-TB Working Group Core Group.

Dr. Keshavjee received his ScM from the Harvard School of Public Health in 1993, his PhD in Anthropology and Middle Eastern Studies from Harvard University in 1998, and his MD from Stanford University in 2001. He completed his clinician-scientist residency in Internal Medicine and a fellowship in Social Medicine at Brigham and Women’s Hospital in 2005. In addition to his appointment with the Department of Global Health and Social Medicine, Dr. Keshavjee serves on the faculty of the Division of Global Health Equity (DGHE) at Brigham and Women’s Hospital (BWH). He is also an attending physician in the Department of Medicine at BWH. He is an affiliate and Steering Committee member at the Harvard Center for Middle Eastern Studies.

More info:

E.g., 2016-10-21
E.g., 2016-10-21
E.g., 2016-10-21
Feb 23rd 2016

Reimagine global health problems with some of the leading global health thinkers and actors through a case-based biosocial framework.

No votes yet